WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis

Oncotarget

Volumn 6, Issue 12, 2015, Pages 10239-10252

  Qin, Li ^a,b,c   Yin, Yan Tao ^c   Zheng, Fang Jing ^a,d   Peng, Li Xia ^a   Yang, Chang Fu ^a   Bao, Ying Na ^a   Liang, Ying Ying ^a   Li, Xin Jian ^a,e   Xiang, Yan Qun ^a   Sun, Rui ^a   Li, An Hua ^a   Zou, Ru Hai ^a   Pei, Xiao Qing ^a   Huang, Bi Jun ^a   Kang, Tie Bang ^a   Liao, Duan Fang ^b   Zeng, Yi Xin ^a   Williams, Bart O ^f   Qian, Chao Nan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

^c UNIVERSITY OF SOUTH CHINA   (China)

^d FUJIAN MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Metastasis; Nasopharyngeal carcinoma; PKC; Tumorigenesis; WNT5A

Indexed keywords

CD24 ANTIGEN; HERMES ANTIGEN; MESSENGER RNA; PROTEIN KINASE C; RECOMBINANT PROTEIN; VIMENTIN; WNT5A PROTEIN; ONCOPROTEIN; WNT PROTEIN; WNT5A PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CANCER PROGNOSIS; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENESIS; CARCINOMA CELL LINE; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; LUNG METASTASIS; LYMPHOCYTE SUBPOPULATION; MALE; METASTASIS POTENTIAL; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; POSITIVE FEEDBACK; TUMOR INVASION; WNT5A GENE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; GENETIC TRANSFECTION; GENETICS; METABOLISM; METASTASIS; NASOPHARYNX TUMOR; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; FEMALE; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; TRANSFECTION; WNT PROTEINS; WNT-5A PROTEIN;

EID: 84929598279     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3518     Document Type: Article

References (46)

1. Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S, Tan IB and Middeldorp JM. Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Chinese journal of cancer. 2012; 31(4):185-196.
2. Cao SM, Simons MJ and Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China. Chinese journal of cancer. 2011; 30(2):114-119.
3. Kataki AC, Simons MJ, Das AK, Sharma K and Mehra NK. Nasopharyngeal carcinoma in the Northeastern states of India. Chinese journal of cancer. 2011; 30(2):106-113.
4. Liu Q, Chen JO, Huang QH and Li YH. Trends in the survival of patients with nasopharyngeal carcinoma between 1976 and 2005 in Sihui, China: a population-based study. Chinese journal of cancer. 2013; 32(6):325-333.
5. Lee AW, Law SC, Foo W, Poon YF, Cheung FK, Chan DK, Tung SY, Thaw M and Ho JH. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence. Int J Radiat Oncol Biol Phys. 1993; 26(5):773-782.
6. Qian CN, Berghuis B, Tsarfaty G, Bruch M, Kort EJ, Ditlev J, Tsarfaty I, Hudson E, Jackson DG, Petillo D, Chen J, Resau JH and Teh BT. Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer research. 2006; 66(21):10365-10376.
7. Li XJ, Ong CK, Cao Y, Xiang YQ, Shao JY, Ooi A, Peng LX, Lu WH, Zhang Z, Petillo D, Qin L, Bao YN, Zheng FJ, Chia CS, Iyer NG, Kang TB, et al. Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis. Cancer research. 2011; 71(8):3162-3172.
8. Li GP, Wang H, Lai YK, Chen SC, Lin MC, Lu G, Zhang JF, He XG, Qian CN and Kung HF. Proteomic profiling between CNE-2 and its strongly metastatic subclone S-18 and functional characterization of HSP27 in metastasis of nasopharyngeal carcinoma. Proteomics. 2011; 11(14):2911-2920.
9. Li XJ, Peng LX, Shao JY, Lu WH, Zhang JX, Chen S, Chen ZY, Xiang YQ, Bao YN, Zheng FJ, Zeng MS, Kang TB, Zeng YX, Teh BT and Qian CN. As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelialmesenchymal transition and activation of AKT signaling. Carcinogenesis. 2012; 33(7):1302-1309.
10. Karim R, Tse G, Putti T, Scolyer R and Lee S. The significance of the Wnt pathway in the pathology of human cancers. Pathology. 2004; 36(2):120-128.
11. Mikels AJ and Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene. 2006; 25(57):7461-7468.
12. Moyes KW, Sip CG, Obenza W, Yang E, Horst C, Welikson RE, Hauschka SD, Folch A and Laflamme MA. Human Embryonic Stem Cell-Derived Cardiomyocytes Migrate in Response to Gradients of Fibronectin and Wnt5a. Stem cells and development. 2013.
13. Povinelli BJ and Nemeth MJ. Wnt5a regulates hematopoietic stem cell proliferation and repopulation through the Ryk receptor. Stem cells. 2014; 32(1):105-115.
14. Wong GT, Gavin BJ and McMahon AP. Differential transformation of mammary epithelial cells by Wnt genes. Mol Cell Biol. 1994; 14(9):6278-6286.
15. Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal DT, Indig FE, Jiang Y, Nickoloff BJ, Taub DD, Trent JM, Moon RT, Bittner M, et al. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. The Journal of biological chemistry. 2007; 282(23):17259-17271.
16. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M and Trent JM. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell. 2002; 1(3):279-288.
17. Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A, Gerstein R, Jurecic R and Jones SN. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell. 2003; 4(5):349-360.
18. Ying J, Li H, Yu J, Ng KM, Poon FF, Wong SC, Chan AT, Sung JJ and Tao Q. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res. 2008; 14(1):55-61.
19. Kremenevskaja N, von Wasielewski R, Rao AS, Schofl C, Andersson T and Brabant G. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene. 2005; 24(13):2144-2154.
20. Dejmek J, Leandersson K, Manjer J, Bjartell A, Emdin SO, Vogel WF, Landberg G and Andersson T. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival. Clin Cancer Res. 2005; 11(2 Pt 1):520-528.
21. Clark CC, Cohen I, Eichstetter I, Cannizzaro LA, McPherson JD, Wasmuth JJ and Iozzo RV. Molecular cloning of the human proto-oncogene Wnt-5A and mapping of the gene (WNT5A) to chromosome 3p14-p21. Genomics. 1993; 18(2):249-260.
22. Huang CL, Liu D, Nakano J, Ishikawa S, Kontani K, Yokomise H and Ueno M. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer. J Clin Oncol. 2005; 23(34):8765-8773.
23. Lejeune S, Huguet EL, Hamby A, Poulsom R and Harris AL. Wnt5a cloning, expression, and up-regulation in human primary breast cancers. Clin Cancer Res. 1995; 1(2):215-222.
24. Saitoh T, Mine T and Katoh M. Frequent up-regulation of WNT5A mRNA in primary gastric cancer. Int J Mol Med. 2002; 9(5):515-519.
25. Pukrop T, Klemm F, Hagemann T, Gradl D, Schulz M, Siemes S, Trumper L and Binder C. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci U S A. 2006; 103(14):5454-5459.
26. Shiozawa Y, Nie B, Pienta KJ, Morgan TM and Taichman RS. Cancer stem cells and their role in metastasis. Pharmacology & therapeutics. 2013; 138(2):285-293.
27. Ortensi B, Setti M, Osti D and Pelicci G. Cancer stem cell contribution to glioblastoma invasiveness. Stem cell research & therapy. 2013; 4(1):18.
28. Abel EV and Simeone DM. Biology and clinical applications of pancreatic cancer stem cells. Gastroenterology. 2013; 144(6):1241-1248.
29. Soave DF, Oliveira da Costa JP, da Silveira GG, Ianez RC, de Oliveira LR, Lourenco SV and Ribeiro-Silva A. CD44/ CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms. Diagnostic pathology. 2013; 8:29.
30. Oliveira LR, Oliveira-Costa JP, Araujo IM, Soave DF, Zanetti JS, Soares FA, Zucoloto S and Ribeiro-Silva A. Cancer stem cell immunophenotypes in oral squamous cell carcinoma. Journal of oral pathology & medicine :official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2011; 40(2):135-142.
31. Chen C, Wei Y, Hummel M, Hoffmann TK, Gross M, Kaufmann AM and Albers AE. Evidence for epithelialmesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PloS one. 2011; 6(1):e16466.
32. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J and Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-715.
33. Dissanayake SK, Olkhanud PB, O'Connell MP, Carter A, French AD, Camilli TC, Emeche CD, Hewitt KJ, Rosenthal DT, Leotlela PD, Wade MS, Yang SW, Brant L, Nickoloff BJ, Messina JL, Biragyn A, et al. Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer research. 2008; 68(24):10205-10214.
34. Huang L, Liang J, Geng Y, Tsang WM, Yao X, Jhanji V, Zhang M, Cheung HS, Pang CP and Yam GH. Directing adult human periodontal ligament-derived stem cells to retinal fate. Investigative ophthalmology & visual science. 2013; 54(6):3965-3974.
35. Kordes C, Sawitza I, Gotze S and Haussinger D. Stellate cells from rat pancreas are stem cells and can contribute to liver regeneration. PloS one. 2012; 7(12):e51878.
36. Li XJ and Qian CN. Serglycin in human cancers. Chinese journal of cancer. 2011; 30(9):585-589.
37. Luo W, Fang W, Li S and Yao K. Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma. International journal of cancer Journal international du cancer. 2012; 131(8):1863-1873.
38. Fong KW, Chua EJ, Chua ET, Khoo-Tan HS, Lee KM, Lee KS, Sethi VK, Tan BC, Tan TW, Wee J and Yang TL. Patient profile and survival in 270 computer tomographystaged patients with nasopharyngeal cancer treated at the Singapore General Hospital. Ann Acad Med Singapore. 1996; 25(3):341-346.
39. Heng DM, Wee J, Fong KW, Lian LG, Sethi VK, Chua ET, Yang TL, Khoo Tan HS, Lee KS, Lee KM, Tan T and Chua EJ. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer. 1999; 86(10):1912-1920.
40. Loong HH, Ma BB and Chan AT. Update on the management and therapeutic monitoring of advanced nasopharyngeal cancer. Hematol Oncol Clin North Am. 2008; 22(6):1267-1278, x.
41. Lun SW, Cheung ST and Lo KW. Cancer stem-like cells in Epstein-Barr virus-associated nasopharyngeal carcinoma. Chinese journal of cancer. 2014; 33(11):529-538.
42. Jonsson M, Smith K and Harris AL. Regulation of Wnt5a expression in human mammary cells by protein kinase C activity and the cytoskeleton. Br J Cancer. 1998; 78(4):430-438.
43. Huber MA, Kraut N and Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005; 17(5):548-558.
44. Kang Y and Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004; 118(3):277-279.
45. Qin L, Zhang X, Zhang L, Feng Y, Weng GX, Li MZ, Kong QL, Qian CN, Zeng YX, Zeng MS, Liao DF and Song LB. Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 2008; 371(3):531-535.
46. Liang Y, Zhong Z, Huang Y, Deng W, Cao J, Tsao G, Liu Q, Pei D, Kang T and Zeng YX. Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. The Journal of biological chemistry. 2010; 285(7):4931-4940.